50% off all subscriptions! ... left. Order NowOrder Now

Dicerna Pharmaceuticals Stock Forecast NASDAQ:DRNA

$37.99 (-0.0263%)

Volume: 11M

Closed: Nov 26, 2021

Hollow Logo Score: 1.914

Dicerna Pharmaceuticals Stock Forecast

$37.99 (-0.0263%)

Volume: 11M

Closed: Nov 26, 2021

Score Hollow Logo 1.914
Which way will DRNA go? Request
Stop-loss: $37.15 (-2.21%)
Key Stats
Beta 1.19
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] RSI14 is 91 and the stock is extremely overbought on RSI14, so further reactions should be expected. Some stocks may have a long and hard correction after reaching so high an RSI, but not in all cases. However, the short-term risk has increased drastically and larger movements in the next couple of days can be expected.

Red day on Friday for Dicerna Pharmaceuticals stock after losing 0.0263%
(Updated on Nov 26, 2021)

Buy or Hold candidate since 2021-10-13 Gain 80.90%

The Dicerna Pharmaceuticals stock price fell by -0.0263% on the last day (Friday, 26th Nov 2021) from $38.00 to $37.99. During the day the stock fluctuated 0.18% from a day low at $37.93 to a day high of $38.00. The price has risen in 5 of the last 10 days and is up by 71.59% over the past 2 weeks. Volume has increased on the last day by 4 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 11 million shares were bought and sold for approximately $415.57 million.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $38.76 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 31.02% during the next 3 months and, with a 90% probability hold a price between $29.03 and $50.78 at the end of this 3-month period.

Signals & Forecast

The Dicerna Pharmaceuticals stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $35.59 and $24.16. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, November 18, 2021, and so far it has fallen -0.11%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

Dicerna Pharmaceuticals finds support from accumulated volume at $37.98 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0700 between high and low, or 0.18%. For the last week, the stock has had a daily average volatility of 0.21%.

The Dicerna Pharmaceuticals stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $37.15 (-2.21%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 91 and this increases the risk substantially. There is a sell signal from a pivot top found 5 days ago.)

Is Dicerna Pharmaceuticals stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Dicerna Pharmaceuticals stock to perform well in the short-term.

Current score: 1.914

Predicted Opening Price for Dicerna Pharmaceuticals of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$37.97 $37.99 (Overvalued)
Buy Candidate Unchanged

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 25, 2021 "SVB Leerink" gave "" rating for DRNA. The price target was set to $38.00+0.1%.

Volatility and Risk
Daily Average Volatility: 0.21 %
Overall Risk: Very High High Medium Low Very Low
0.21 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $38.00
Price: $37.99
Support: $37.98

DRNA Insider Trading Show all Trades



Last 100 transactions
Buy: 360 748 | Sell: 440 609 (Shares)
Date Action Amount Person Type
Nov 18, 2021 Sell 24 936 Brown Bob D Employee Stock Option (Right to Buy)
Nov 18, 2021 Sell 24 936 Brown Bob D Common Stock
Nov 18, 2021 Buy 24 936 Brown Bob D Common Stock
Sep 17, 2021 Sell 21 250 Brown Bob D Common Stock
Sep 17, 2021 Sell 2 056 Aradhye Shreeram Common Stock
Show all Insider Trades


Last 100 transactions
Buy: 360 748 | Sell: 440 609 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 38.04 0.14 %
38.02 0.0700 %
38.00 0.0265 %
Current price: 37.99
Support 37.95 -0.11 %
37.93 -0.16 %
37.90 -0.23 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0 .
38.03 0.11 %
38.00 0.0263 %
Current price 37.99
Support 37.98 -0.0263%
37.92 -0.18%
0 .

Click to get the best stock tips daily for free!

About Dicerna Pharmaceuticals

Dicerna Pharmaceuticals Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria type 1 (PH1) through targeting the gene encoding the liver enzyme glycolate oxidase; and other rare inherit... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE